Delivery Order SPE2DB22D2214-SPE2DB24FS6WH

Award Date 9/27/24
Potential Completion Date 9/30/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $4,909.62 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is to supply 4,565,531,240 units of the pharmaceutical product Eliquis 5 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities from...
This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $10,912.37, is for the supply of Eliquis 5mg tablets. This order supports DLA Troop Support Medical's provision of pharmaceutical products to military treatment facilities and other federal healthcare providers. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 IDC with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,550 units of the medication Eliquis 5 mg tablets. The fixed-price contract has a ceiling value of $1,928.58 and a period of performance through August 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,948.68 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Eliquis 5 mg tablets over the period ending on September 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $22,028.57, is for the supply of Eliquis 5 mg tablets. The delivery order was issued under an Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, which has a potential value of up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $5,777.75 and an ultimate completion date of September 5, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division to provide 4,565,911,241 Eliquis 5 mg tablets. The fixed-price contract, valued at $3,025.68, has a period of performance through September 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the supply of a wide range of pharmaceutical and medical...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The order is for 4,565,803,432 units of Eliquis 5 mg tablets, a pharmaceutical product used to treat cardiovascular conditions. The contract has a ceiling value of $13,158.53 and an ultimate completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This $10,592.20 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Eliquis 5 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide....
This is a $17,726.51 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets over a period ending on March 6, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS6WH
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $3,721.47, is for the supply of 4,565,964,621 units of Eliquis 5 mg tablets. The order was placed under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. This IDC allows the DLA to efficiently procure a wide range of pharmaceutical and medical supplies from AmerisourceBergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by September 30, 2024.

Generated 12/27/24, 9:14 AM